Researchers have discovered a new way to drive chemical reactions that could generate a wide variety of azetidines -- four-membered nitrogen heterocycles that have desirable pharmaceutical properties.
Mark Burchnall, director of engineering at PSN Labs, will present "Optimizing Medical Device Development: Integrating Physical and Virtual Prototyping for Rapid Commercialization," at MD&M West 2025, ...
A computational biology company that started in space tech is looking to change how biopharma finds disease targets by ...
The National Academies will convene a committee to organize a workshop on navigating the benefits and biosecurity risks of communicating studies involving the use of computational modeling and ...
When chemists design new chemical reactions, one useful piece of information involves the reaction's transition state—the point of no return from which a reaction must proceed. This information allows ...
CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, today announced the expansion of its Contract Research Services (CRS ...
When severe weather strikes, the National Weather Service's (NWS) Office of Water Prediction (OWP) makes critical flood ...
CAMBRIDGE, MA — Researchers from MIT and the University of Michigan have discovered a new way to drive chemical reactions that could generate a wide variety of compounds with desirable pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results